Almond Butter and Fasting Glucose
| Status: | Recruiting |
|---|---|
| Conditions: | Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - 75 |
| Updated: | 3/13/2019 |
| Start Date: | March 8, 2019 |
| End Date: | June 1, 2020 |
| Contact: | Emily A Johnston, MPH, RDN, CDE |
| Email: | exj22@psu.edu |
| Phone: | 9737685888 |
Almond Butter and Fasting Glucose in Adults With Type 2 Diabetes
A two-period randomized crossover study will be conducted to determine the effect of almond
butter as an evening snack on fasting blood glucose in adults with type 2 diabetes, not
taking insulin.
butter as an evening snack on fasting blood glucose in adults with type 2 diabetes, not
taking insulin.
Control of fasting blood glucose is a challenge for many individuals with diabetes.
Researchers want to better understand how a nighttime snack can affect morning fasting blood
glucose. A two-period randomized crossover trial will be conducted. Participants will be
randomized to receive each treatment for 1 week. During the almond butter treatment,
participants will consume 2 tbsp of almond butter per day as an evening snack. The control
treatments will be a no-snack control. Fasting blood glucose, as well as glucose trends, will
be measured using Continuous Glucose Monitor (CGM). Participants will also be asked to take
simple cognitive tests on a study-provided smartphone each day of the study and report their
daily food intake and physical activity.
Researchers want to better understand how a nighttime snack can affect morning fasting blood
glucose. A two-period randomized crossover trial will be conducted. Participants will be
randomized to receive each treatment for 1 week. During the almond butter treatment,
participants will consume 2 tbsp of almond butter per day as an evening snack. The control
treatments will be a no-snack control. Fasting blood glucose, as well as glucose trends, will
be measured using Continuous Glucose Monitor (CGM). Participants will also be asked to take
simple cognitive tests on a study-provided smartphone each day of the study and report their
daily food intake and physical activity.
Inclusion Criteria:
- Individuals with diagnosed type 2 diabetes
- Not on insulin therapy
- On stable does of oral antihyperglycemic agent (no dose change for 6 months)
- Currently monitoring blood glucose at home via glucometer
- Willing and able to adhere to study protocol
Exclusion Criteria:
- Individuals with type 1 diabetes, cardiovascular disease, kidney disease, liver
disease, cancer or inflammatory conditions (e.g. GI disorders, rheumatoid arthritis)
- Women who are pregnant, breastfeeding, or have been pregnant within the last 6 months
or breastfeeding within the last 6 weeks
- Individuals who smoke or use tobacco products
- Use of insulin therapy or sulfonylurea medications
- Allergy to any tree nut
- Liver or kidney disease
- Allergy to Dexcom CGM adhesive
We found this trial at
1
site
Click here to add this to my saved trials
